Producer
Aarti Pharmalabs
Indian API/intermediate maker; supplier of various pharmaceutical actives.
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Aarti Pharmalabs supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Aarti Pharmalabs makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
APIs & intermediates
Xanthine derivatives
CDMO / contract manufacturing
Specialty & agro intermediates
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2024
Aarti Pharmalabs is a major global maker of xanthines — caffeine and its chemical relatives, theophylline and theobromine. Most people assume the caffeine in their energy drink, soda or supplement comes from coffee or tea, but the bulk of it is synthetic caffeine, manufactured by a handful of chemical companies in India and China, Aarti among them. The same xanthine chemistry also makes pharmaceutical actives: theophylline for asthma and COPD, and the caffeine added to combination painkillers like Excedrin. So a pharma-intermediates company sits behind both the jolt in an energy drink and the caffeine in a headache pill — and the world's caffeine supply, in food and medicine alike, traces to industrial synthesis concentrated in a few Indian and Chinese makers, not to beans and leaves. The "natural" association of caffeine hides a concentrated chemical-manufacturing reality, where a single factory's output reaches both the beverage aisle and the pharmacy shelf.
Aarti Pharmalabs Ltd. ↗Concentration2024
Like Zydus, Aarti embodies India's role as a pharmaceutical-chemistry workshop — it makes APIs, advanced intermediates and runs contract manufacturing (CDMO) for global drug companies. So the active ingredients and building-block molecules of many medicines are made by Indian specialty-chemical firms, another layer in the India-and-China-centered drug supply chain. As Western firms seek to de-risk from China, Indian intermediate makers like Aarti are positioned to capture more of that chemistry — though they, too, often depend on Chinese starting materials, so "moving out of China" frequently means moving one step, not the whole chain. So Aarti sits in the contested middle of the global effort to reshape where the world's medicines are actually synthesized — a quiet but strategically important tier where the resilience (or fragility) of the drug supply is really decided, well upstream of the branded pill.
Aarti Pharmalabs Ltd. ↗